Cat. No.: HY-12583

A-366

7 Cited Publications

고객리뷰

Based on 7 publication(s) in Google Scholar

A-366, a chemical probe, is a potent, highly selective, peptide-competitive histone methyltransferase G9a inhibitor with IC₅₀s of 3.3 and 38 nM for G9a and GLP (EHMT1), respectively. A-366 shows >1000-fold selectivity over 21 other methyltransferases. A-366 is also a potent, nanomolar inhibitor of the Spindlin1-H3K4me3-interaction (IC₅₀=182.6 nM). A-366 displays high affinity at human histamine H3 receptor (K_i=17 nM) and shows subtype selectivity among subsets of the histaminergic and dopaminergic receptor families.

연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.

Purity: 98.13%
CAS No.: 1527503-11-2
화학식: C₁₉H₂₇N₃O₂
분자량:329.44

보관:

Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month

A-366 Chemical Structure

CAS No.: 1527503-11-2

사이즈

가격

재고

수량

Amount: USD 0.00

* 장바구니에 담기 전 물품의 수량을 선택해 주십시오.

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biological Activity
- 제품 설명
- IC₅₀ & Target
- Cellular Effect
- In Vitro
- In Vivo
Chemical Information
Publications (7)
용액&용해도
- In Vitro
- In Vivo
순도&문서
References
Help & FAQs
Classifications
Bioz

Biological Activity

제품 설명

IC₅₀ & Target

EHMT2/G9a/KMT1C

EHMT1/GLP/KMT1D

All Histone Methyltransferase Isoforms :

All Epigenetic Reader Domain Isoforms :

Cellular Effect

Cell Line	Type	Value	Description	References
Calu-1	EC₅₀	>10 μM Compound: Chemical probe: A-366	Antiproliferative against human Calu-1 cells after 5 days by Cell-Titer Glo assay Antiproliferative against human Calu-1 cells after 5 days by Cell-Titer Glo assay	[PMID: 26147105]
Calu-6	EC₅₀	>10 μM Compound: Chemical probe: A-366	Antiproliferative against human Calu-6 cells after 5 days by Cell-Titer Glo assay Antiproliferative against human Calu-6 cells after 5 days by Cell-Titer Glo assay	[PMID: 26147105]
CWR22R	EC₅₀	>10 μM Compound: Chemical probe: A-366	Antiproliferative against human 22RV1 cells after 5 days by Cell-Titer Glo assay Antiproliferative against human 22RV1 cells after 5 days by Cell-Titer Glo assay	[PMID: 26147105]
Daoy	EC₅₀	>10 μM Compound: Chemical probe: A-366	Antiproliferative against human Daoy cells after 7 days by Cell-Titer Glo assay Antiproliferative against human Daoy cells after 7 days by Cell-Titer Glo assay	[PMID: 26147105]
DU-145	EC₅₀	>10 μM Compound: Chemical probe: A-366	Antiproliferative against human DU-145 cells after 5 days by Cell-Titer Glo assay Antiproliferative against human DU-145 cells after 5 days by Cell-Titer Glo assay	[PMID: 26147105]
G-401	EC₅₀	>10 μM Compound: Chemical probe: A-366	Antiproliferative against human G-401 cells after 7 days by Cell-Titer Glo assay Antiproliferative against human G-401 cells after 7 days by Cell-Titer Glo assay	[PMID: 26147105]
HL-60	EC₅₀	>10 μM Compound: Chemical probe: A-366	Antiproliferative against human HL-60 cells after 5 days by Cell-Titer Glo assay Antiproliferative against human HL-60 cells after 5 days by Cell-Titer Glo assay	[PMID: 26147105]
HT-1080	EC₅₀	>10 μM Compound: Chemical probe: A-366	Antiproliferative against human HT-1080 cells after 5 days by Cell-Titer Glo assay Antiproliferative against human HT-1080 cells after 5 days by Cell-Titer Glo assay	[PMID: 26147105]
IMR-32	EC₅₀	>10 μM Compound: Chemical probe: A-366	Antiproliferative against human IMR-32 cells after 7 days by Cell-Titer Glo assay Antiproliferative against human IMR-32 cells after 7 days by Cell-Titer Glo assay	[PMID: 26147105]
K562	EC₅₀	>10 μM Compound: Chemical probe: A-366	Antiproliferative against human K562 cells after 5 days by Cell-Titer Glo assay Antiproliferative against human K562 cells after 5 days by Cell-Titer Glo assay	[PMID: 26147105]
Kasumi 1	EC₅₀	>10 μM Compound: Chemical probe: A-366	Antiproliferative against human Kasumi-1 cells after 5 days by Cell-Titer Glo assay Antiproliferative against human Kasumi-1 cells after 5 days by Cell-Titer Glo assay	[PMID: 26147105]
KMS-11	EC₅₀	>10 μM Compound: Chemical probe: A-366	Antiproliferative against human KMS-11 cells after 5 days by Cell-Titer Glo assay Antiproliferative against human KMS-11 cells after 5 days by Cell-Titer Glo assay	[PMID: 26147105]
KMS-12-BM	EC₅₀	>10 μM Compound: Chemical probe: A-366	Antiproliferative against human KMS-12-BM cells after 5 days by Cell-Titer Glo assay Antiproliferative against human KMS-12-BM cells after 5 days by Cell-Titer Glo assay	[PMID: 26147105]
L-363	EC₅₀	>10 μM Compound: Chemical probe: A-366	Antiproliferative against human L-363 cells after 5 days by Cell-Titer Glo assay Antiproliferative against human L-363 cells after 5 days by Cell-Titer Glo assay	[PMID: 26147105]
LN-229	EC₅₀	>10 μM Compound: Chemical probe: A-366	Antiproliferative against human LN-229 cells after 5 days by Cell-Titer Glo assay Antiproliferative against human LN-229 cells after 5 days by Cell-Titer Glo assay	[PMID: 26147105]
LNCaP	EC₅₀	>10 μM Compound: Chemical probe: A-366	Antiproliferative against human LNCaP cells after 5 days by Cell-Titer Glo assay Antiproliferative against human LNCaP cells after 5 days by Cell-Titer Glo assay	[PMID: 26147105]
MOLT-16	EC₅₀	>10 μM Compound: Chemical probe: A-366	Antiproliferative against human MOLT-16 cells after 5 days by Cell-Titer Glo assay Antiproliferative against human MOLT-16 cells after 5 days by Cell-Titer Glo assay	[PMID: 26147105]
MV4-11	EC₅₀	>10 μM Compound: Chemical probe: A-366	Antiproliferative against human MV4-11 cells after 5 days by Cell-Titer Glo assay Antiproliferative against human MV4-11 cells after 5 days by Cell-Titer Glo assay	[PMID: 26147105]
NCI-H1975	EC₅₀	>10 μM Compound: Chemical probe: A-366	Antiproliferative against human NCI-H1975 cells after 5 days by Cell-Titer Glo assay Antiproliferative against human NCI-H1975 cells after 5 days by Cell-Titer Glo assay	[PMID: 26147105]
NCI-H2009	EC₅₀	>10 μM Compound: Chemical probe: A-366	Antiproliferative against human NCI-H2009 cells after 5 days by Cell-Titer Glo assay Antiproliferative against human NCI-H2009 cells after 5 days by Cell-Titer Glo assay	[PMID: 26147105]
NCI-H358	EC₅₀	>10 μM Compound: Chemical probe: A-366	Antiproliferative against human NCI-H358 cells after 5 days by Cell-Titer Glo assay Antiproliferative against human NCI-H358 cells after 5 days by Cell-Titer Glo assay	[PMID: 26147105]
NCI-H441	EC₅₀	>10 μM Compound: Chemical probe: A-366	Antiproliferative against human NCI-H441 cells after 5 days by Cell-Titer Glo assay Antiproliferative against human NCI-H441 cells after 5 days by Cell-Titer Glo assay	[PMID: 26147105]
NCI-H522	EC₅₀	>10 μM Compound: Chemical probe: A-366	Antiproliferative against human NCI-H522 cells after 5 days by Cell-Titer Glo assay Antiproliferative against human NCI-H522 cells after 5 days by Cell-Titer Glo assay	[PMID: 26147105]
NCI-H661	EC₅₀	>10 μM Compound: Chemical probe: A-366	Antiproliferative against human NCI-H661 cells after 5 days by Cell-Titer Glo assay Antiproliferative against human NCI-H661 cells after 5 days by Cell-Titer Glo assay	[PMID: 26147105]
NCI-H929	EC₅₀	>10 μM Compound: Chemical probe: A-366	Antiproliferative against human NCI-H929 cells after 5 days by Cell-Titer Glo assay Antiproliferative against human NCI-H929 cells after 5 days by Cell-Titer Glo assay	[PMID: 26147105]
OPM-2	EC₅₀	>10 μM Compound: Chemical probe: A-366	Antiproliferative against human OPM-2 cells after 5 days by Cell-Titer Glo assay Antiproliferative against human OPM-2 cells after 5 days by Cell-Titer Glo assay	[PMID: 26147105]
PA-1	EC₅₀	>10 μM Compound: Chemical probe: A-366	Antiproliferative against human PA-1 cells after 7 days by Cell-Titer Glo assay Antiproliferative against human PA-1 cells after 7 days by Cell-Titer Glo assay	[PMID: 26147105]
RPMI-8226	EC₅₀	>10 μM Compound: Chemical probe: A-366	Antiproliferative against human RPMI-8226 cells after 5 days by Cell-Titer Glo assay Antiproliferative against human RPMI-8226 cells after 5 days by Cell-Titer Glo assay	[PMID: 26147105]
RS4-11	EC₅₀	>10 μM Compound: Chemical probe: A-366	Antiproliferative against human RS4-11 cells after 5 days by Cell-Titer Glo assay Antiproliferative against human RS4-11 cells after 5 days by Cell-Titer Glo assay	[PMID: 26147105]
Sf9	IC₅₀	11 nM Compound: A-366	Inhibition of N-terminal GST tagged human recombinant EHMT1 (794 to 1294 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in conversion of SAH to AMP using histone H3 as substrate and SAH as cosubstrate incubated for 30 m Inhibition of N-terminal GST tagged human recombinant EHMT1 (794 to 1294 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in conversion of SAH to AMP using histone H3 as substrate and SAH as cosubstrate incubated for 30 m	[PMID: 31350126]
Sf9	IC₅₀	13 nM Compound: A-366	Inhibition of N-terminal GST tagged human recombinant EHMT2 (785 to 1210 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in conversion of SAH to AMP using histone H3 as substrate and SAH as cosubstrate incubated for 30 m Inhibition of N-terminal GST tagged human recombinant EHMT2 (785 to 1210 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in conversion of SAH to AMP using histone H3 as substrate and SAH as cosubstrate incubated for 30 m	[PMID: 31350126]
SK-BR-3	EC₅₀	>10 μM Compound: Chemical probe: A-366	Antiproliferative against human SK-BR-3 cells after 5 days by Cell-Titer Glo assay Antiproliferative against human SK-BR-3 cells after 5 days by Cell-Titer Glo assay	[PMID: 26147105]
SK-N-MC	EC₅₀	>10 μM Compound: Chemical probe: A-366	Antiproliferative against human SK-N-MC cells after 7 days by Cell-Titer Glo assay Antiproliferative against human SK-N-MC cells after 7 days by Cell-Titer Glo assay	[PMID: 26147105]
THP-1	EC₅₀	>10 μM Compound: Chemical probe: A-366	Antiproliferative against human THP-1 cells after 5 days by Cell-Titer Glo assay Antiproliferative against human THP-1 cells after 5 days by Cell-Titer Glo assay	[PMID: 26147105]
U2OS	EC₅₀	>10 μM Compound: Chemical probe: A-366	Antiproliferative against human U2OS cells after 7 days by Cell-Titer Glo assay Antiproliferative against human U2OS cells after 7 days by Cell-Titer Glo assay	[PMID: 26147105]
ZR-75-30	EC₅₀	>10 μM Compound: Chemical probe: A-366	Antiproliferative against human ZR-75-30 cells after 7 days by Cell-Titer Glo assay Antiproliferative against human ZR-75-30 cells after 7 days by Cell-Titer Glo assay	[PMID: 26147105]

In Vitro

A-366 (0.01-10 μM; 14 days) induces differentiation and affects viability in MV4;11 cells^[4].
A-366 (0.3-3 μM; 72 hours) reduces the total levels of H3K9me2 in a time and concentration dependent manner with a cellular EC50 of ~300 nM in PC-3 prostate adenocarcinoma cells. A-366 (0.01-10 μM; 4 days; HL-60 cells) results in a dose-dependent differentiation and a corresponding decrease in proliferation. DNA content analysis of A-366-treated HL-60 cells showed an accumulation of cells in G1 consistent with cytostasis^[4].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay^[4]

Cell Line:

MV4;11 cells
Concentration:

0.01-10 μM
Incubation Time:

14 days
Result:

Resulted in inhibited proliferation and a decrease in viability corresponding to the dose response observed for CD11b staining.

In Vivo

A-366 (30 mg/kg; osmotic mini-pump; daily for 14 days) treatment of MV4;11 xenografts elicits growth inhibition^[4].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:

6-8 week old SCID-beige female mice (MV4;11 xenografts)^[4]
Dosage:

30 mg/kg
Administration:

By osmotic mini-pump; daily for 14 days
Result:

A modest 45% tumor growth inhibition resulting from A-366 treatment in this model.

Chemical Information

CAS No. 1527503-11-2
Appearance Solid
분자량 329.44
화학식 C₁₉H₂₇N₃O₂
Color Light yellow to yellow
SMILES

COC1=CC2=C(N=C(N)C23CCC3)C=C1OCCCN4CCCC4
선적

Room temperature in continental US; may vary elsewhere.

보관

Powder	-20°C	3 years
	4°C	2 years
In solvent	-80°C	6 months
	-20°C	1 month

Publications (7)

All Bio/Physico-chemical Assay

Sort by:

Journal Impact Factor

Cancer Res

TNG917 is a Potent and Selective Inhibitor of Histone Lysine Methyltransferases EHMT1/2 that Enhances Anti-Tumor Immunity and Immunotherapy Efficacy. [Abstract]

2026 Jun 10. PMID: 42268285
Nat Commun

Human iPSC-based Modeling of Pulmonary Fibrosis Reveals p300/CBP Inhibition Suppresses Alveolar Transitional Cell State. [Abstract]

2026 Feb 12;17(1):1214. PMID: 41680175
Theranostics

G9a stimulates CRC growth by inducing p53 Lys373 dimethylation-dependent activation of Plk1. [Abstract]

2018 Apr 15;8(10):2884-2895. PMID: 29774081
Proc Natl Acad Sci U S A

MGMT-activated DUB3 stabilizes MCL1 and drives chemoresistance in ovarian cancer. [Abstract]

2019 Feb 19;116(8):2961-2966. PMID: 30718431
Diabetes

Molecular Mechanisms of Human Pancreatic Islet Dysfunction Under Overnutrition Metabolic Stress. [Abstract]

2025 Oct 1;74(10):1825-1838. PMID: 40773375

A-366 purchased from MedChemExpress. Usage Cited in: Diabetes. 2025 Oct 1;74(10):1825-1838. [Abstract]

Insulin secretion, normalized by total content, of EndoC-βH1 cells treated with A-366 under different conditions.

A-366 purchased from MedChemExpress. Usage Cited in: Diabetes. 2025 Oct 1;74(10):1825-1838. [Abstract]

Principal component (PC) analysis of the RNA-seq data shows the separation of samples along two axes corresponding to glucolipotoxicity (GL) treatment and A-366.

A-366 purchased from MedChemExpress. Usage Cited in: Diabetes. 2025 Oct 1;74(10):1825-1838. [Abstract]

RRHO map comparing the differential expression of GL vs. Ctrl (x-axis) and A-366 vs. on drug (y-axes).
iScience

Transcriptional synergy in human aortic endothelial cells is vulnerable to combination p300/CBP and BET bromodomain inhibition. [Abstract]

2024 May 16;27(6):110011. PMID: 38868181
Epigenetics Chromatin

H3K9 post-translational modifications regulate epiblast/primitive endoderm specification in rabbit blastocysts. [Abstract]

2025 Jan 13;18(1):2. PMID: 39800758

용액&용해도

In Vitro:

DMSO : 50 mg/mL (151.77 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

View the Complete Stock Solution Preparation Table

Preparing Stock Solutions

View the Complete Stock Solution Preparation Table

Concentration Solvent Mass

1 mg

5 mg

10 mg

Concentration

Solvent

Mass

1 mM

3.0355 mL

15.1773 mL

30.3545 mL

5 mM

0.6071 mL

3.0355 mL

6.0709 mL

10 mM

0.3035 mL

1.5177 mL

3.0355 mL

Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.

Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

몰농도 계산기

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Concentration Concentration

Volume Volume

Molecular Weight Molecular Weight

농도 희석 계산기

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

Concentration _(start) Concentration _(start)

Volume _(start) Volume _(start)

Concentration _(final) Concentration _(final)

Volume _(final) Volume _(final)

In Vivo:

Select the appropriate dissolution method based on your experimental animal and administration route.

Stock Solution Working Solution

For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

Protocol 1

Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline

Solubility: ≥ 2.5 mg/mL (7.59 mM); Clear solution

This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

Protocol 2

Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)

Solubility: ≥ 2.5 mg/mL (7.59 mM); Clear solution

This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.

In Vivo Dissolution Calculator

Please enter the basic information of animal experiments:

Dosage Dosage
mg/kg
Animal Weight (Per Animal) Animal Weight (Per Animal)
g
Dosing Volume (Per Animal) Dosing Volume (Per Animal)
μL
Number of Animals Number of Animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Please enter your animal formula composition:

%
DMSO +

Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
%
+
+
%
Tween-80 + +
%
Saline +

The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).

Working solution concentration: 0.22 mg/mL

순도&문서

Select Batch:

Purity: 99.98%

Assay: 99.98%

ee.: 99.98%

Data Sheet (277 KB)
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
COA (2659 KB)
Elemental Analysis Report (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
Handling Instructions (2659 KB)

References

[1]. Reiner D, et al. Epigenetics meets GPCR: inhibition of histone H3 methyltransferase (G9a) and histamine H3 receptor for Prader-Willi Syndrome. Sci Rep. 2020;10(1):13558. Published 2020 Aug 11. [Content Brief]

[2]. Wagner T, et al. Identification of a small-molecule ligand of the epigenetic reader protein Spindlin1 via a versatile screening platform. Nucleic Acids Res. 2016;44(9):e88. [Content Brief]

[3]. Sweis RF, et al. Discovery and development of potent and selective inhibitors of histone methyltransferase g9a. ACS Med Chem Lett. 2014;5(2):205-209. Published 2014 Jan 2. [Content Brief]

[4]. Pappano WN, et al. The Histone Methyltransferase Inhibitor A-366 Uncovers a Role for G9a/GLP in the Epigenetics of Leukemia. PLoS One. 2015;10(7):e0131716. Published 2015 Jul 6. [Content Brief]

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Complete Stock Solution Preparation Table

Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Optional Solvent	Concentration Solvent Mass	1 mg	5 mg	10 mg	25 mg
DMSO	1 mM	3.0355 mL	15.1773 mL	30.3545 mL	75.8864 mL
	5 mM	0.6071 mL	3.0355 mL	6.0709 mL	15.1773 mL
	10 mM	0.3035 mL	1.5177 mL	3.0355 mL	7.5886 mL
	15 mM	0.2024 mL	1.0118 mL	2.0236 mL	5.0591 mL
	20 mM	0.1518 mL	0.7589 mL	1.5177 mL	3.7943 mL
	25 mM	0.1214 mL	0.6071 mL	1.2142 mL	3.0355 mL
	30 mM	0.1012 mL	0.5059 mL	1.0118 mL	2.5295 mL
	40 mM	0.0759 mL	0.3794 mL	0.7589 mL	1.8972 mL
	50 mM	0.0607 mL	0.3035 mL	0.6071 mL	1.5177 mL
	60 mM	0.0506 mL	0.2530 mL	0.5059 mL	1.2648 mL
	80 mM	0.0379 mL	0.1897 mL	0.3794 mL	0.9486 mL
	100 mM	0.0304 mL	0.1518 mL	0.3035 mL	0.7589 mL

Keywords

상품명:
Cat. No.:
수량:
MCE Japan Authorized Agent:

상품명:
CAS No.:
Species:
Purity:
수량:

A-366

Epigenetics Compound Library

Histone Modification Research Compound Library

Anti-Cancer Compound Library

Reprogramming Compound Library

Chemical Probe Library

Anti-Blood Cancer Compound Library

Heterocyclic Compound Library

Highly Selective Inhibitors Library

Anti-Hematopathy Compound Library

Multi-Target Compound Library

Bioactive Compound Library Max

MCE Bioactive Compound Library

Bioactive Compound Library

Methylation Compound Library

High-Throughput Bioactive Compound Library

Posttranslational Modification Library

Publications Citing Use of MedChemExpress (MCE) A-366

All Histone Methyltransferase Isoforms

All Epigenetic Reader Domain Isoforms

Biological Activity

Chemical Information

Publications (7)

용액&용해도

순도&문서

References

Help & FAQs

Complete Stock Solution Preparation Table

A-366

Epigenetics Compound Library

Histone Modification Research Compound Library

Anti-Cancer Compound Library

Reprogramming Compound Library

Chemical Probe Library

Anti-Blood Cancer Compound Library

Heterocyclic Compound Library

Highly Selective Inhibitors Library

Anti-Hematopathy Compound Library

Multi-Target Compound Library

Bioactive Compound Library Max

MCE Bioactive Compound Library

Bioactive Compound Library

Methylation Compound Library

High-Throughput Bioactive Compound Library

Posttranslational Modification Library

Publications Citing Use of MedChemExpress (MCE) A-366

All Histone Methyltransferase Isoforms

All Epigenetic Reader Domain Isoforms

Biological Activity

Chemical Information

Publications (7)

용액&용해도

순도&문서

References

Help & FAQs

Complete Stock Solution Preparation Table

A-366 Related Classifications

HY-12583 Related Classifications